Upon relocation to Dosho-machi, Higashi-ku, Osaka, Towa Pharmaceutical Co., Ltd (abbreviated as Towa) is established and incorporated. The Gamo Plant is established at Gamo-cho, Jyoto-ku, Osaka.

Neyagawa Plant is established at Kamikamida, Neyagawa, Osaka. Gamo Plant is closed and unified to Neyagawa Plant.

Towa moves its corporate headquarters to new office in Matsuo-cho, Kadoma, Osaka.

The Kadoma Plant is constructed at Kuwazai-shinmachi, Kadoma, Osaka.

The Osaka Plant is established at the headquarters site. Neyagawa Plant is unified to Osaka Plant and Kadoma Plant. Kadoma Laboratory is established at Kuwazai-shinmachi, Kadoma, Osaka. Distribution Center is established in Fukata-cho, Kadoma, Osaka.

Osaka Plant Annex is constructed at Yanagida-cho, Kadoma, Osaka. Laboratory enlarges to conform to GLP.

The Okayama Plant is constructed at the Shoo Industrial Park in Okayama.

Towa acquires Beppu Hot Spring Science Institute Ltd., renames it Oita Plant, and starts manufacturing injections there.

Kadoma Plant is closed and unified to Osaka Plant and Okayama Plant.

Three sales company, Towa Pharmaceutical Sales Co., Ltd., Hanshin Towa Pharmaceutical Sales Co., Ltd., and Towa Pharmaceutical Tokyo sales Co., Ltd. are consolidated.

The Oita Plant is sold to Heisei Pharmaceutical Co., Ltd. and demerges the company.

Heisei Pharmaceutical Co., Ltd. is merged and Oita Plant re-starts production.

Towa's shares are listed on the over-the-counter market of the Japan Securities Dealers Association.

Distribution center is established in the Okayama Plant site.

Towa moves its corporate headquarters to newly built office in Shinbashi-cho, Kadoma, Osaka.

Osaka Research Center and Osaka Distribution Center are established at Ichiban-cho, Kadoma, Osaka.
Towa purchases Mect Co., Ltd.'s Tohoku Plant, re-opens it as Yamagata Daiichi Plant.

Towa purchases J-Dolph Co., Ltd., and makes it consolidated subsidiary.

Towa's shares are listed on the second of Tokyo Stock Exchange (TSE).

Listing of Towa's share transfers to the first section of TSE.

Osaka Daini Plant is closed and unified to the Osaka plant which is established at Matsuo-cho, Kadoma, Japan.

Oita Plant is closed and unified to the Okayama plant.

"Amlodipine OD tablet 'Towa'" wins the Generic Drug of the Year 2009 Award.

Towa purchases Daichi Kasei Co., Ltd., and makes it consolidated subsidiary.
"Levofloxacin oral solution 25mg/mL 'Towa'" wins "2010 Excellent Generic Promotion Award."
"RACTAB Technologies" wins "Asahi Kasei Encouragement Award of Pharmaceutics" from Academy of Pharmaceutical Science and Technology.

The New Yamagata Plant is planned to be established at Kaminoyama, Yamagata.